• GILEAD SCIENCES INC Financial Overview

  • Income Statement: GILD

      2007 2006 Change ( 2006 - 2007  )
    Net Sales/Revenues 4.23 B 3.03 B 1.20 B 28.46%
    Gross Profit 3.46 B 2.59 B 868.46 M 25.09%
    Net Income Before Extra Items/Preferred Div 1.62 B -1.19 B 2.81 B 173.67%
    Operating Income 2.16 B 1.64 B 529.21 M 24.45%
  • Cash Flow: GILD

      2007 2006 Change ( 2006 - 2007  )
    Net Cash Flow - Financing -267.30 M 649.26 M -916.56 M 342.90%
    Net Cash Flow - Investing 1.30 B 1.74 B -436.87 M -33.54%
    Net Cash Flow/Operating Activities 1.77 B 1.22 B 547.34 M 31.00%
  • Balance Sheet: GILD

      2007 2006 Change ( 2006 - 2007  )
    Total Assets 5.54 B 3.78 B 1.75 B 31.67%
    Total Liabilities 1.94 B 1.91 B 22.44 M 1.16%
    Shareholders Equity 3.46 B 1.82 B 1.64 B 47.52%
  • Key Ratios / Statistics: GILD

    • Valuation

      Price/Earnings (TTM) 27.39
      Price/Sales (TTM) 10.49
      Price/Book (MRQ) 12.95
      Price/Cash Flow (TTM) 24.18
    • Profitability

      Gross Margin 81.83
      Operating Margin 51.17
      Profit Margin 38.19
    • Dividends

      Dividend Paid (TTM) 0.00
      Payout Ratio % (TTM) 0.00
    • Financial Strength

      Quick Ratio (MRQ) 2.67
      Current Ratio (MRQ) 1.50
      Long Term Debt-to-Equity (MRQ) 0.00
    • Management Effectiveness

      Return on Equity (TTM) 61.14
      Return on Assets (TTM) 32.76
      Return on Investments (TTM) 39.70